XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Common Stock Issuable
Accumulated Deficit
Balance, shares at Dec. 31, 2019   38,001,543      
Balance, amount at Dec. 31, 2019 $ 13,507,000 $ 38,000 $ 63,035,000 $ 1,066,000 $ (50,632,000)
Issuance of common stock for professional services, shares   31,250      
Issuance of common stock for professional services, amount 231,000 $ 0 68,000 163,000  
Fair value of stock options and restricted stock granted 469,000   469,000    
Fair value of restricted stock units granted 60,000   60,000    
Net loss 2,046,000       2,046,000
Balance, shares at Mar. 31, 2020   38,032,793      
Balance, amount at Mar. 31, 2020 16,313,000 $ 38,000 63,632,000 1,229,000 (48,586,000)
Balance, shares at Dec. 31, 2019   38,001,543      
Balance, amount at Dec. 31, 2019 13,507,000 $ 38,000 63,035,000 1,066,000 (50,632,000)
Net loss (14,144,000)        
Balance, shares at Sep. 30, 2020   51,219,519      
Balance, amount at Sep. 30, 2020 24,624,000 $ 51,000 88,777,000 572,000 (64,776,000)
Balance, shares at Mar. 31, 2020   38,032,793      
Balance, amount at Mar. 31, 2020 16,313,000 $ 38,000 63,632,000 1,229,000 (48,586,000)
Issuance of common stock for professional services, shares   218,750      
Issuance of common stock for professional services, amount 189,000 $ 0 600,000 (411,000)  
Fair value of stock options and restricted stock granted 479,000   479,000    
Fair value of restricted stock units granted 60,000   60,000    
Net loss (13,439,000)       (13,439,000)
Issuance of common stock from the equity incentive plan, shares   8,003      
Issuance of common stock from the equity incentive plan, amount 0 $ 0 0    
Issuance of common stock from exercise of warrants, shares   708,467      
Issuance of common stock from exercise of warrants, amount 1,418,000 $ 1,000 1,417,000    
Issuance of common stock from settlement with Chemistry Holdings, Inc., shares   12,058,623      
Issuance of common stock from settlement with Chemistry Holdings, Inc., amount 21,701,000 $ 12,000 21,935,000 (246,000)  
Balance, shares at Jun. 30, 2020   51,026,636      
Balance, amount at Jun. 30, 2020 26,721,000 $ 51,000 88,123,000 572,000 (62,025,000)
Issuance of common stock for professional services, shares   31,250      
Issuance of common stock for professional services, amount 49,000 $ 0 49,000 0  
Fair value of stock options and restricted stock granted 515,000   515,000    
Fair value of restricted stock units granted 68,000   68,000    
Net loss (2,751,000)       (2,751,000)
Issuance of common stock from the equity incentive plan, shares   161,633      
Issuance of common stock from the equity incentive plan, amount 22,000 $ 0 22,000    
Balance, shares at Sep. 30, 2020   51,219,519      
Balance, amount at Sep. 30, 2020 24,624,000 $ 51,000 88,777,000 572,000 (64,776,000)
Balance, shares at Dec. 31, 2020   59,476,268      
Balance, amount at Dec. 31, 2020 21,279,000 $ 60,000 101,807,000 665,000 (81,253,000)
Issuance of common stock for professional services, shares   265,512      
Issuance of common stock for professional services, amount 508,000 $ 0 363,000 145,000  
Fair value of stock options and restricted stock granted 961,000   961,000    
Fair value of restricted stock units granted 144,000   144,000    
Net loss (3,171,000)       (3,171,000)
Issuance of common stock from the equity incentive plan, shares   157,693      
Issuance of common stock from the equity incentive plan, amount 138,000 $ 0 190,000 (52,000)  
Issuance of common stock for exercise of warrants, shares   26,936      
Issuance of common stock for exercise of warrants, amount 0 $ 0 0 0  
Balance, shares at Mar. 31, 2021   59,926,409      
Balance, amount at Mar. 31, 2021 19,859,000 $ 60,000 103,465,000 758,000 (84,424,000)
Balance, shares at Dec. 31, 2020   59,476,268      
Balance, amount at Dec. 31, 2020 21,279,000 $ 60,000 101,807,000 665,000 (81,253,000)
Net loss (8,835,000)        
Balance, shares at Sep. 30, 2021   65,060,044      
Balance, amount at Sep. 30, 2021 18,585,000 $ 66,000 108,004,000 603,000 (90,088,000)
Balance, shares at Mar. 31, 2021   59,926,409      
Balance, amount at Mar. 31, 2021 19,859,000 $ 60,000 103,465,000 758,000 (84,424,000)
Issuance of common stock for professional services, shares   381,000      
Issuance of common stock for professional services, amount 243,000 $ 0 243,000    
Fair value of stock options and restricted stock granted 591,000   591,000    
Fair value of restricted stock units granted 143,000   143,000    
Net loss (1,321,000)       (1,321,000)
Issuance of common stock from the equity incentive plan, shares   141,693      
Issuance of common stock from the equity incentive plan, amount (157,000) $ 0 (2,000) (155,000)  
Issuance of common stock from conversion of convertible promissory notes, shares   2,428,857      
Issuance of common stock from conversion of convertible promissory notes, amount 1,835,000 $ 3,000 1,832,000    
Balance, shares at Jun. 30, 2021   62,877,959      
Balance, amount at Jun. 30, 2021 21,193,000 $ 63,000 106,272,000 603,000 (85,745,000)
Issuance of common stock for professional services, amount 0        
Fair value of stock options and restricted stock granted 532,000   532,000    
Fair value of restricted stock units granted 156,000   156,000    
Net loss (4,343,000)       (4,343,000)
Issuance of common stock from the equity incentive plan, shares   572,975      
Issuance of common stock from the equity incentive plan, amount 0 $ 1,000 (1,000)    
Issuance of common stock from conversion of convertible promissory notes, shares   1,609,110      
Issuance of common stock from conversion of convertible promissory notes, amount 1,047,000 $ 2,000 1,045,000    
Balance, shares at Sep. 30, 2021   65,060,044      
Balance, amount at Sep. 30, 2021 $ 18,585,000 $ 66,000 $ 108,004,000 $ 603,000 $ (90,088,000)